The Aerosol Assault: How Vaping Recodes Lung Immunity
Every single day, your body negotiates a truce with the outside world at the alveolar-capillary interface: the thinnest barrier in the human body. Measuring a mere 0.2 to 0.4 micrometers thick, way thinner than a single sheet of paper, this microscopic wall is one of the most highly specialized structures in human anatomy. It focuses on seamless, rapid gas exchange: allowing oxygen to diffuse into the bloodstream while carbon dioxide escapes.
Recently, this delicate structure has been endlessly abused. Instead of the clean air that the interface is adapted to exchange, the modern lung is being bombarded with ultra-fine thermal aerosols generated by electronic cigarettes. Because this barrier is built for gas diffusion, it possesses virtually no physical armor against the chemical and particulate onslaught of vaping, forcing the respiratory immune system to rewire itself.
The MedTech of the Vape: Thermal Degradation and Aerosol Physics
To understand the biological damage, one must first look at the engineering of the device itself. A vape is a complex thermal reactor, not a passive delivery system.
When a user activates an e-cigarette, a battery heats a metallic coil—typically composed of nickel, chromium, or kanthal—to temperatures exceeding 200 degrees Celsius to 300 degrees Celsius. At these extreme temperatures, the e-liquid undergoes thermal degradation, fracturing into new chemical compounds. Simultaneously, the physical stress on the heating elements causes microscopic leaching, releasing toxic metallic nanoparticles directly into the vaporized stream.
The danger of these particles is determined by the laws of fluid dynamics. E-cigarette aerosols have liquid droplets suspended in gas, with particle sizes ranging from ultra-fine to sub-micron. When breathing in tiny floating particles, size changes where they land in your body; larger particles get trapped in the throat and upper airway, while smaller particles bypass the upper respiratory tracts entirely. They ride the inhalation current into the terminal bronchioles and alveoli, settling directly into the lung’s primary immune zones.
Inside the Lab: The Fluorescent Proof of Immune Paralysis
To uncover exactly what happens when these particles breach the deep lung, researchers at UC San Diego are looking directly at our first line of defense: neutrophils and macrophages. These immune cells are tasked with releasing chemicals to kill pathogens, physically engulfing invaders (a process known as phagocytosis), and releasing signals to orchestrate the broader immune response.
“To perform these functions, immune cells need to detect and respond to pathogens by triggering the appropriate internal signaling cascades,” explains Dr. Alexia Perryman, a postdoctoral scholar in Dr. Laura Crotty Alexander’s pulmonary immunology lab at UC San Diego.
To visualize this under the microscope, Perryman and her team expose immune cells to fluorescently labeled fragments of bacteria or fungi. Under normal conditions, healthy cells actively devour these fragments, lighting up under the microscope. The brighter the fluorescence, the more active the immune defense.
However, when the cells are exposed to vaping chemicals, the lights go dim.
“When neutrophils and macrophages are exposed to vaping-related chemicals and then given these same fluorescently labeled fragments, we see significantly less fluorescence,” Perryman notes. “This means the cells are failing to engulf pathogens the way they should.”
Crucially, she points out that the vape chemicals are not necessarily killing the immune cells entirely, rather it is a subtle system failure. There is a complete breakdown between the cell’s ability to detect a pathogen and its ability to respond to it. The internal signaling processes are scrambled, rendering the cells immunologically paralyzed.
Digging Deeper: The “Nicotine-Free” Illusion and Moving Targets
This cellular issue is further complicated by the rapidly evolving chemistry of e-liquids. Vape juices contain an overwhelming variety of chemical flavorings that are deemed “Generally Recognized as Safe” (GRAS) for ingestion by the FDA, but ingestion via the stomach is entirely different from inhalation into the fragile alveoli.
“There are a vast number of different vaping products available that are constantly changing, making it impossible to model them all in a single lab,” says Perryman. “Further complicating this, the chemical composition of e-liquids changes when they are heated and aerosolized.”
Perryman highlights a particularly alarming trend currently hitting the market: products labeled as “nicotine-free” that actually contain synthetic nicotine analogues.
“These nicotine analogues can still act like nicotine and can be even more potent, meaning it takes a lower concentration to produce the same effect,” Perryman warns. “This is just one example of how the marketing of vaping products can be misleading, and it highlights the need to understand both the chemical composition and the biological effects of what is actually being inhaled.”
By analyzing samples ranging from cell cultures to the respiratory tracts of human vapers, the Crotty Alexander Lab has mapped a troubling dual-effect. Vaping drives up inflammatory cytokines (which suggests a harsh, pro-inflammatory environment) while simultaneously depressing vital immune markers. The body is trapped in a state of chronic inflammation, and is stripped of its ability to fight off a standard lung infection.
Future Tech: From Air-Liquid Interfaces to Breathalyzer Diagnostics
How do scientists safely model this damage without relying solely on animal testing? The solution lies in advanced bioengineering.
Traditionally, lab cells are studied under submerged conditions, completely covered in a liquid nutrient media. While this works well for floating immune cells, studying epithelial cells under liquid does not quite match how they live in the human body. The old set up did not take this crucial distinction into account: immune cells float naturally in liquid blood, while lung cells naturally face the open air. Drowning lung cells in liquid media creates an unrealistic environment, failing to capture how real lungs breathe. To bridge this gap, the lab utilizes Air-Liquid Interface (ALI) cultures.
In an ALI setup, respiratory epithelial cells are grown on a porous membrane. They drink nutrients from the media below while their top side is exposed directly to the air, allowing researchers to puff aerosolized vape smoke across them just like a human airway.
While ALI cultures are a massive step forward, Perryman notes that they still have limitations. They cannot replicate the lung’s complex, 3D “upside-down tree” architecture, the interactions of dozens of cell types, or the physical stretch of taking a breath. To solve this, bioengineers are actively developing advanced lung-on-a-chip microfluidic systems to introduce physical mechanical forces into the equation.
Innovation in the lab has shown promising clinical impact, as Perryman proposed a device for consumers and clinicians alike to unmask the moving target of illegal, unregulated vapes.
“I think it would be valuable to have a device that could analyze the chemical composition of what is being inhaled, and simultaneously measure biomarkers in [the user’s] exhaled breath,” Perryman envisions. “This would allow us to track inhalant exposures in real time and link them directly to changes in respiratory health.”
Historically, it took nearly sixty years of data to definitively prove that cigarette smoking causes lung cancer. By combining real-time exposure tracking with advanced cellular modeling, UC San Diego researchers and bioengineers are working to drastically shorten that timeline, using modern MedTech to decode the threats to our lungs before the damage becomes irreversible.†
Written by Staff Writer Matea Palman (mpalman@ucsd.edu)
Works Cited
Leiby, Katherine L., Micha Sam Brickman Raredon, and Laura E. Niklason. “Bioengineering the Blood-gas Barrier.” Comprehensive Physiology, vol. 10, no. 2, 2020, pp. 415-452. PubMed Central.
Madison, M. C., et al. (2019). Electronic cigarettes disrupt lung lipid homeostasis and alter innate immunity. Journal of Clinical Investigation.
Olmedo, Pablo, et al. "Metal Concentrations in e-Cigarette Liquid and Aerosol Samples: The Contribution of Metallic Coils." Environmental Health Perspectives, vol. 126, no. 2, 2018, p. 027002. PubMed Central.
Setyan, A., et al. (2019). Characterization of Particle Size Distribution and Volatility of E-Cigarette Aerosols. Atmospheric Environment.




Comments